- Greenway Greenhouse Cannabis Corporation (GWAY) has updated on its inventory, the development of a new product, and the retrofit of its cultivation space
- It maintained its inventory over the past five fiscal quarters which it plans to sell through
- A new strain, Strain X, is becoming commercially available and is a sativa leaning hybrid
- Its expansion plan is still on time and on budget to be operational by early 2023
- Greenway Greenhouse Cannabis Corporation (GWAY) is unchanged trading at $0.64 per share as of 1:49 p.m. ET
Greenway Greenhouse Cannabis Corporation (GWAY) has provided an update regarding inventory, the development of a new product, and the retrofit of its cultivation space.
The company stated it has maintained its inventory over the past five fiscal quarters and is not accumulating any more.
“Greenway has not destroyed any finished product. This is why we started the company at a small scale, as a right sized operator – so we can focus on quality and sell what we grow,” Darren Peddle, CFO of Greenway, said.
Greenway also announced a new strain, Strain X, that is becoming commercially available. The strain is a sativa leaning hybrid, that brings a unique smell and flavour profile.
“This strain is completely unique to Greenway and helps expand our offerings to more fully represent all of the distinct demands of the cannabis consumer… first full batch has already presold, proving how well it adds itself to our current offerings “said Carl Mastronardi, President of Greenway.
Greenway also stated its expansion plan is still on time and on budget to be operational by early 2023.
“The retrofit of both our greenhouse and production areas remains both on time and on budget, something we could not have done without the experience and dedication of our leadership team,” Jamie D’Alimonte, CEO of Greenway, said.
Greenway Greenhouse Cannabis Corporation (GWAY) is unchanged trading at $0.64 per share as of 1:49 p.m. ET.
